TBC1D22A Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIPA532019-Each-of-1 | In Stock | ₹ 46,502.50 |
PIPA532019 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 46,502.50
GST (18%): ₹ 8,370.45
Total Price: ₹ 54,872.95
Antigen
TBC1D22A
Classification
Polyclonal
Conjugate
Unconjugated
Gene
TBC1D22A
Gene Alias
BC023106; C22orf4; D15Ertd781e; HSC79E021; putative GTPase activator; RGD1306588; TBC1 domain family member 22A; TBC1 domain family, member 22a; TBC1D22A
Host Species
Rabbit
Purification Method
Antigen affinity chromatography
Regulatory Status
RUO
Gene ID (Entrez)
25771
Content And Storage
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Form
Liquid
Applications
Immunohistochemistry (Paraffin), Western Blot
Concentration
1 mg/mL
Formulation
PBS with 1% BSA, 20% glycerol and 0.01% thimerosal; pH 7
Gene Accession No.
Q8WUA7
Gene Symbols
TBC1D22A
Immunogen
Recombinant fragment corresponding to a region within amino acids 11 and 315 of Human TBC1D22A
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Human
Product Type
Antibody
Isotype
IgG
Related Products
Description
- Recommended positive controls: A431, HeLa, HepG2
- Predicted reactivity: Mouse (85%), Bovine (82%)
- Store product as a concentrated solution
- Centrifuge briefly prior to opening the vial
- TBC1D22A (TBC1 domain family, member 22A), also known as C22orf4, is a 517 amino acid protein that contains one Rab-GAP TBC domain and is thought to function as a GTPase-activating protein for Rab family members
- Multiple isoforms of TBC1D22A exist due to alternative splicing events
- The gene encoding TBC1D22A maps to human chromosome 22, which houses over 500 genes and is the second smallest human chromosome
- Mutations in several of the genes that map to chromosome 22 are involved in the development of Phelan-McDermid syndrome, neurofibromatosis type 2, autism and schizophrenia
- Additionally, translocations between chromosomes 9 and 22 may lead to the formation of the Philadelphia chromosome and the subsequent production of the novel fusion protein BCR-Abl, a potent cell proliferation activator found in several types of leukemias.